Paper12192535
Anti-tumor activities of the angiogenesis inhibitors interferon-inducible protein-10 and the calreticulin fragment vasostatin.
Yao L and 6 others. Cancer Immunol Immunother, 2002. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Anti-tumor activities of the angiogenesis inhibitors interferon-inducible protein-10 and the calreticulin fragment vasostatin. Papers, record 12192535. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12192535
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Anti-tumor activities of the angiogenesis inhibitors interferon-inducible protein-10 and the calreticulin fragment vasostatin.
- PubMed
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angiogenesis Inhibitors | Major topic |
| Antineoplastic Agents | Major topic |
| Burkitt Lymphoma | Major topic |
| Calcium-Binding Proteins | Major topic |
| Chemokine CXCL10 | Major topic |
| Neovascularization, Pathologic | Major topic |
| Peptide Fragments | Major topic |
| Ribonucleoproteins | Major topic |
| Actins | |
| Animals | |
| Apoptosis | |
| Calreticulin | |
| Cell Division | |
| Drug Evaluation, Preclinical | |
| Drug Synergism | |
| Endothelium, Vascular | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Nude | |
| Muscle, Smooth, Vascular | |
| Platelet Endothelial Cell Adhesion Molecule-1 | |
| Recombinant Fusion Proteins | |
| Xenograft Model Antitumor Assays |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32244946 | Viral Pathogenesis, Recombinant Vaccines, and Oncolytic Virotherapy: Applications of the Canine Distemper Virus Reverse Genetics System. | Viruses | 2020 | https://conductscience.org/library/papers/32244946 | PubMed |
| 29731871 | Co-implantation of bone marrow mesenchymal stem cells and chondrocytes increase the viability of chondrocytes in rat osteo-chondral defects. | Oncol Lett | 2018 | https://conductscience.org/library/papers/29731871 | PubMed |
| 29075268 | Calreticulin Fragment 39-272 Promotes B16 Melanoma Malignancy through Myeloid-Derived Suppressor Cells In Vivo. | Front Immunol | 2017 | https://conductscience.org/library/papers/29075268 | PubMed |
| 27462315 | Is the Antitumor Property of Trypanosoma cruzi Infection Mediated by Its Calreticulin? | Front Immunol | 2016 | https://conductscience.org/library/papers/27462315 | PubMed |
| 26573090 | Mutant calreticulin-expressing cells induce monocyte hyperreactivity through a paracrine mechanism. | Am J Hematol | 2016 | https://conductscience.org/library/papers/26573090 | PubMed |
| 25629005 | Is it all That Bad When Living with an Intracellular Protozoan? The Role of Trypanosoma cruzi Calreticulin in Angiogenesis and Tumor Growth. | Front Oncol | 2014 | https://conductscience.org/library/papers/25629005 | PubMed |
| 24997628 | Plasmid-encoding vasostatin inhibited the growth and metastasis of human hepatocellular carcinoma cells. | Mol Cell Biochem | 2014 | https://conductscience.org/library/papers/24997628 | PubMed |
| 24921409 | Viral oncolysis - can insights from measles be transferred to canine distemper virus? | Viruses | 2014 | https://conductscience.org/library/papers/24921409 | PubMed |
| 21291541 | Lymphocyte deficiency limits Epstein-Barr virus latent membrane protein 1 induced chronic inflammation and carcinogenic pathology in vivo. | Mol Cancer | 2011 | https://conductscience.org/library/papers/21291541 | PubMed |
| 20625551 | Antiangiogenic and antitumor effects of Trypanosoma cruzi Calreticulin. | PLoS Negl Trop Dis | 2010 | https://conductscience.org/library/papers/20625551 | PubMed |
| 19940256 | Calreticulin: non-endoplasmic reticulum functions in physiology and disease. | FASEB J | 2010 | https://conductscience.org/library/papers/19940256 | PubMed |
| 19542426 | Modulating the expression of IFN regulatory factor 8 alters the protumorigenic behavior of CD11b+Gr-1+ myeloid cells. | J Immunol | 2009 | https://conductscience.org/library/papers/19542426 | PubMed |
| 19470579 | IP-10 induces dissociation of newly formed blood vessels. | J Cell Sci | 2009 | https://conductscience.org/library/papers/19470579 | PubMed |
| 18662403 | Secretion of biologically active interferon-gamma inducible protein-10 (IP-10) by Lactococcus lactis. | Microb Cell Fact | 2008 | https://conductscience.org/library/papers/18662403 | PubMed |
| 18066596 | Synergistic antitumor effect of CXCL10 with hyperthermia. | J Cancer Res Clin Oncol | 2008 | https://conductscience.org/library/papers/18066596 | PubMed |
| 16756670 | Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray. | Virol J | 2006 | https://conductscience.org/library/papers/16756670 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CALR | 811 | PubTator's text mining | https://conductscience.org/library/genes/811 | NCBI Gene |
| CXCL10 | 3627 | PubTator's text mining | https://conductscience.org/library/genes/3627 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12192535
GET https://conductscience.org/api/papers/v1/12192535/authors